3Coabs RB, Jensen P, Her MH, et al. Review of the scientific literature on the prevalence, consequences and health costs of noncompliance and inappropricate use of preacripton medication in Canada: health promotion research[ M]. University of Toronto Press, 1995: 76.
4Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence [ J ]. Med Care, 1986,24( 1 ) :67.
10Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975- 2010, National Cancer Institute. Bethesda, MDEEB/ OL]. http://seer, cancer, gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
3Patricia Flatley Brennan,Gail R,Casper Laura J,et al.Technology enhanced practice for patients with chronic cardiac disease Home Implementation and Evaluation[J].Published in final edited form a(sHeart Lung),2010,39(6Suppl):S34-S46.
4Health Quality Ontario.Specialized Nursing Practice for Chronic Disease Management in the Primary Care Setting:An Evidence-Based Analysis[J].Ont Health Technol Assess Ser,2013,13(10):1-66.
